These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Treatment of tardive dyskinesia with tetrabenazine or valbenazine: a systematic review. Caroff SN; Aggarwal S; Yonan C J Comp Eff Res; 2018 Feb; 7(2):135-148. PubMed ID: 28965423 [TBL] [Abstract][Full Text] [Related]
6. Valbenazine as the first and only approved treatment for adults with tardive dyskinesia. Sarva H; Henchcliffe C Expert Rev Clin Pharmacol; 2018 Mar; 11(3):209-217. PubMed ID: 29338466 [TBL] [Abstract][Full Text] [Related]
8. Valbenazine granted breakthrough drug status for treating tardive dyskinesia. Müller T Expert Opin Investig Drugs; 2015 Jun; 24(6):737-42. PubMed ID: 25809133 [TBL] [Abstract][Full Text] [Related]
9. Revisiting Tardive Dyskinesia: Focusing on the Basics of Identification and Treatment. Citrome L; Saklad SR J Clin Psychiatry; 2020 Feb; 81(2):. PubMed ID: 32078259 [TBL] [Abstract][Full Text] [Related]
10. Valbenazine (Ingrezza) for tardive dyskinesia. Med Lett Drugs Ther; 2017 May; 59(1521):83-84. PubMed ID: 28520698 [No Abstract] [Full Text] [Related]
11. Efficacy of Valbenazine (NBI-98854) in Treating Subjects with Tardive Dyskinesia and Schizophrenia or Schizoaffective Disorder. Kane JM; Correll CU; Liang GS; Burke J; O'Brien CF Psychopharmacol Bull; 2017 Aug; 47(3):69-76. PubMed ID: 28839342 [TBL] [Abstract][Full Text] [Related]
12. Efficacy of Valbenazine (NBI-98854) in Treating Subjects with Tardive Dyskinesia and Mood Disorder. Correll CU; Josiassen RC; Liang GS; Burke J; O'Brien CF Psychopharmacol Bull; 2017 Aug; 47(3):53-60. PubMed ID: 28839340 [TBL] [Abstract][Full Text] [Related]
13. Valbenazine and deutetrabenazine: Vesicular monoamine transporter 2 inhibitors for tardive dyskinesia. Khorassani F; Luther K; Talreja O Am J Health Syst Pharm; 2020 Jan; 77(3):167-174. PubMed ID: 31974564 [TBL] [Abstract][Full Text] [Related]
14. Treatment of tardive dyskinesia with VMAT-2 inhibitors: a systematic review and meta-analysis of randomized controlled trials. Solmi M; Pigato G; Kane JM; Correll CU Drug Des Devel Ther; 2018; 12():1215-1238. PubMed ID: 29795977 [TBL] [Abstract][Full Text] [Related]
15. Valbenazine for the treatment of tardive dyskinesia. Barquero N Drugs Today (Barc); 2016 Dec; 52(12):665-672. PubMed ID: 28276538 [TBL] [Abstract][Full Text] [Related]
16. Valbenazine in the treatment of tardive dyskinesia. Witek N; Comella C Neurodegener Dis Manag; 2019 Apr; 9(2):73-81. PubMed ID: 30724115 [TBL] [Abstract][Full Text] [Related]